Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Li

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Journal of Medicinal Chemistry|October 27, 2022
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput ScreeningXinrong Tian, Dominic Suarez, Douglas Thomson, et al.
Addiction (Abingdon, England)|September 12, 2020
Physicians' very brief (30-sec) intervention for smoking cessation on 13 671 smokers in China: a pragmatic randomized controlled trialYee Tak Derek Cheung, Nan Jiang, Chao Qiang Jiang, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Journal of Medicinal Chemistry|October 27, 2022
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput ScreeningXinrong Tian, Dominic Suarez, Douglas Thomson, et al.
Addiction (Abingdon, England)|September 12, 2020
Physicians' very brief (30-sec) intervention for smoking cessation on 13 671 smokers in China: a pragmatic randomized controlled trialYee Tak Derek Cheung, Nan Jiang, Chao Qiang Jiang, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Pageof 12